University of Maryland School of Medicine logo
Emergency Medicine
All Departments
UMSOM Assistant
UMEM Educational Pearls
  • Home
  • Departments
  • Emergency Medicine
  • CME
  • UMEM Educational Pearls
  • CME
  • Courses and Conferences
  • Free Open Access Medical Education
  • UMEM Educational Pearls

Search

Title: Tapentadol: A new opioid analgesic

Category: Toxicology

Keywords: tapentadol, nucynta, opioid (PubMed Search)

Posted: 5/12/2011 by Bryan Hayes, PharmD (Updated: 7/21/2026)

Several patients have recently presented with a medication history including tapentadol (Nucynta), the newest opioid formulation.  It is approved for treatment of acute moderate-severe pain.  Here are some key points:

  • Mechanism similar to tramadol: mu-receptor agonist, also inhibits norepinephrine reuptake
  • Potency stronger than tramadol, but less then morphine
  • Usual dose is same as tramadol 50-100 mg every 4-6 hours prn pain
  • Schedule II controlled substance, similar to morphine/oxycodone (tramadol is not a controlled substance)
  • Overdose should present like other opioids, but potentially also including tachycardia, serotonergic effects, and seizures (similar to tramadol)

University of Maryland School of Medicine logo
  • Departments
  • Programs
  • Research Centers
  • Institutes
  • Graduate Education
  • CIBR Cores
  • Offices of the Dean
    • University of Maryland, Baltimore
    • University of Maryland Medical Center
    • Medical Alumni Association of the University of Maryland
    • Health Sciences and Human Services Library
University of Maryland School of Medicine
655 W. Baltimore Street
Baltimore, MD 21201
Contact Us

© University of Maryland School of Medicine

    • Webmaster
    • Web Accessibility
    • Site Index
    • UMB Hotline
    • Employment
    • Map